ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2937

Evaluation of Referral Models for Axial Spondyloarthritis in Primary Care in the Spondyloarthritis Caught Early Cohort

Ozair Abawi1, Rosaline van den Berg1, Désirée van der Heijde2 and Floris van Gaalen1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Referrals and axial spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis V - Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose  Several models have been proposed to refer patients (pts) with possible axial spondyloarthritis (axSpA) from primary care to the rheumatologist. Aim of the study was to evaluate performance of referral models for axSpA in the SPondyloArthritis Caught Early (SPACE) cohort.

Methods  Ten referral models were found in literature and tested in the Leiden SPACE cohort, including pts with back pain (≥3 months, ≤2 years, onset <45 years; n=192) referred to the rheumatology outpatient clinic of the LUMC. Imaging was omitted from all models if included as a referral parameter, as it is unfeasible for screening in primary care. [table 1]

Performance of the models was evaluated (sensitivity, specificity, positive predictive value, positive likelihood ratio) using classification by ASAS axSpA criteria as external standard. For pts not fulfilling the ASAS criteria who are referred, post-test probability for axSpA was calculated based on the LR product for presence of SpA features. A LR product ≥78 equals a post-test probability ≥80% and was used as cut-off for probable axSpA. Pts who were incorrectly not referred met the ASAS axSpA criteria by fulfilling the clinical arm only or the imaging arm (imaging arm only or both arms). [table 2]

Results
 In total, 74/192 pts fulfilled ASAS axSpA criteria; 48 with positive imaging (n=15 radiographic sacroiliitis). Most models performed well regarding sensitivity/specificity. Braun alt. model has the most balanced sensitivity/specificity and highest LR+. All models that include HLA B27 miss axSpA pts with positive imaging, 14-23% with radiographic sacroiliitis (depending on the model). PPV of the models is low, indicating that many pts are referred despite not fulfilling axSpA criteria. However, 6-16% (depending on the model) of these pts have a post-test probability ≥80% for axSpA. This reflects that these pts are rightly referred, despite not fulfilling the axSpA criteria.

Conclusion  Most referral models performed well in the SPACE cohort. However, this cohort includes pts already referred from primary care, probably causing overestimation of performance of all models. All models miss pts fulfilling the ASAS imaging arm, 14-23% of which have radiographic sacroiliitis, which is highly undesirable. Moreover, large numbers of pts referred unnecessarily might lead to a burden for health care systems. Further studies should be conducted in primary care to evaluate these models in their target population. 

References
1Brandt ARD 2007;66:1479-84
2Braun Rheum 2013;52:1418-24
3Poddubnyy J Rheum 2011;38:2452-60
4Sieper ARD 2013;72:1621-7
5Weel AC&R 2013-09-19


Disclosure:

O. Abawi,
None;

R. van den Berg,
None;

D. van der Heijde,
None;

F. van Gaalen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-referral-models-for-axial-spondyloarthritis-in-primary-care-in-the-spondyloarthritis-caught-early-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology